# Pre-diltiazem, Calcium Versus Placebo for Atrial Fibrillation With Rapid Ventricular Response

> **NCT05691959** · PHASE2 · UNKNOWN · sponsor: **Ascension Health** · enrollment: 378 (estimated)

## Conditions studied

- Atrial Fibrillation With Rapid Ventricular Response
- Hypotension

## Interventions

- **DRUG:** Placebo
- **DRUG:** Calcium

## Key facts

- **NCT ID:** NCT05691959
- **Lead sponsor:** Ascension Health
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-01-26
- **Primary completion:** 2025-01-31
- **Final completion:** 2025-01-31
- **Target enrollment:** 378 (ESTIMATED)
- **Last updated:** 2023-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05691959

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05691959, "Pre-diltiazem, Calcium Versus Placebo for Atrial Fibrillation With Rapid Ventricular Response". Retrieved via MORVS 2026-10-12 from https://api.morvs.ai/clinical/NCT05691959. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*